BBlogFlow

Caribbean countries strengthen action to prevent drowning - Pan American Health Organization (PAHO)

·Oct 8, 2026
Source: Pan American Health Organization (PAHO)
Read the original article

This story deserves to be shared

Send it to someone who'd care, or post it on your networks.

Facebook Twitter Email

Bridgetown, Barbados, 5 October 2026 (PAHO/WHO) – Representatives from countries and territories across the Caribbean came together in Barbados to strengthen national and regional action to prevent drowning and build safer, more resilient communities. The Caribbean Community Drowning Prevention Workshop, held from 1–5 October 2026, brought together practitioners, programme administrators, academics and representatives of government agencies and civil society organizations involved in drowning prevention across the region. The workshop was hosted by the Royal Life Saving Society Commonwealth (RLSS) and co-hosted by the World Health Organization (WHO) and the Pan American Health Organization (PAHO) as well as the Royal National Lifeboat Institution. Drowning remains an important public health concern. Approximately 17,000 people died from drowning in the Region of the Americas in 2021, representing a mortality rate of 1.6 per 100,000 population. Drowning also remains the seventh leading cause of death among children aged 5 to 14 years in the Region.

This article is an excerpt. To read the full content, visit the original source. Pan American Health Organization (PAHO)

Reactions

0 comments

No comments yet. Be the first to share your thoughts!

Facebook Twitter

Related articles

Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.

Medical Xpress·

Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily

“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.

Oncodaily·